Product Name ： Kelp P.E.
Active Ingredient ： Fucoidan
Specification ： Polysaccharides 10%, 15%, 30%, 95%
Test mothed ： UV
CAS NO ： 9072-19-9
Appearance ： Yellow brown fine powder or white fine powder
Part used ： Leaf
Applicable Industries ： Medicine, Functional Food
Function ： Anti-clotting, blood fat, anti-tumor and anti-HIV effect
Package ： In fiber-drums with two-plastic bags inside
Storage ： Stored in dry and cool place, keep away from strong light and heat
Shelf Life ： 2 year
Kelp powder introduction:
Kelp powder is a kind of very good processing forms, facilitate storage, transportation and sales, also can further processed into other food.
Process water soaking raw materials and kelp and deodorization - air - and chop - dry - crushing - sifting - finished kelp - powder
Pharmacological Function:
It has the function of anti -clotting, blood fat; Anti-tumor and anti -HIV effects. It has a good effect on the treatment of nephrotic syndrome and early-medium of chronic renal failure, non -taxic side effects, sepecially on the improvement of renal function and lowering serum creatinine obviously.
Suggested Applications:
1.For medicine nature active ingredient for curing tumor, heart and blood vessel disease as well as kindly malfunction etc.
2. To produce antioxidizing, blood fat reducing and immunity enhancing health foods.
3. For high grade of cosmetic due to its good Humectant and nutritional character.
4. Also for agriculture industry.in regulating plant mechanism it has special function.
Fucoxanthin (FX) is the second most prominent carotenoid in the earth's biomass. It is the primary carotenoid in some forms of brown algae. FX has been shown to reduce visceral adipose in mice and humans and is being incorporated into dietary supplements for weight loss. To examine the content of commercial FX products, we developed and validated Normal-Phase and Reversed-Phase HPLC methods to measure FX. Dietary supplements were purchased from local suppliers and over the internet. Samples were extracted into methanol prior to HPLC analysis. The NPLC was performed on a Diol column using a mobile phase of 6%IPA in hexane while monitoring 450nm. The RPLC was performed on a C30 column using a gradient of methanol, water, and ethyl acetate while monitoring 450nm. Samples tested contained various forms of seaweed or seaweed extracts. Products with stated FX content ranged from 250mcg to 5mg/unit. The products exhibit quite different carotenoid profiles and some do not meet label-claims for FX. Due to current levels of obesity and increased use of thermogenic supplements, these methods will be useful to monitor the FX in current and future supplements.